BIOFORCE NANOSCIENCES HOLDINGS, INC.

Unregistered Sales of Equity Securities

Beneficial ownership report for a holder of more than 5% (Schedule 13D)

Regulation FD Disclosure

Other Events

General form for quarterly reports under Section 13 or 15(d)

Other Events

Other Events

Changes in Control of Registrant

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

Notification of late filing of Form 10-Q

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

Notification of late filing of Form 10-K

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

4.01,9.01

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

Annual report pursuant to Section 13 or 15(d)

General form for quarterly reports under Section 13 or 15(d)

5.02,9.01

8.01

3.02

Other Events

8.01

8.01

8.01

8.01

3.02

Letter from the SEC

Definitive information statement

No description available

No description available

Correspondence with the SEC

No description available

Letter from the SEC

No description available

Letter from the SEC

No description available

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

Correspondence with the SEC

No description available

Letter from the SEC

No description available

8.01

Certification of termination of registration of a class of securities (Section 12(g))

Entry into a Material Definitive Agreement

2.04,9.01

7.01,9.01

Prospectus Supplement for Primary Offering

Notice of Effectiveness

Post-effective amendment to a registration statement

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Post-effective amendment to a registration statement

Definitive Proxy Statement

Prospectus Supplement for Primary Offering

Notice of Effectiveness

No description available

No description available

Letter from the SEC

Correspondence with the SEC

No description available

No description available

No description available

Nexus Capital Investments, Inc.

Mager Scott

KAISER RICHARD KAISER

Ferguson Merle

Ferguson Merle

Ferguson Merle

Ferguson Merle

Ferguson Merle

Ferguson Merle

KAISER RICHARD KAISER

KAISER RICHARD KAISER

Ferguson Merle

KAISER RICHARD KAISER

Ferguson Merle

KAISER RICHARD KAISER

Ferguson Merle

KAISER RICHARD KAISER

Donohue Susan

Ferguson Merle